ロード中...
Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma
Abstract: Background and Objective: Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs) are effective against lung adenocarcinoma. However, limited data is available assessing the effectiveness of EGFR-TKI use in preventing re-accumulation of MPE. To our knowledge, there is no li...
保存先:
| 出版年: | Curr Drug Discov Technol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Bentham Science Publishers
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4997927/ https://ncbi.nlm.nih.gov/pubmed/27216707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570163813666160524142846 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|